×
About 3,604 results

ALLMedicine™ Hypoparathyroidism Center

Research & Reviews  1,575 results

Autofluorescence and Indocyanine Green in Thyroid Surgery: A Systematic Review and Meta...
https://doi.org/10.1002/lary.29297
The Laryngoscope BIBLIOGRAPHY; Barbieri D, Indelicato P et. al.

Nov 28th, 2020 - To estimate the impact of optical techniques on prevention of post-operative hypocalcemia and hypoparathyroidism after total thyroidectomy. Systematic review and meta-analysis. A literature search was conducted in Pubmed, EMBASE, SCOPUS, and Cochr...

Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide Analogs.
https://doi.org/10.1210/endocr/bqaa216
Endocrinology Daley EJ, Khatri A et. al.

Nov 26th, 2020 - LA-PTH is a long-acting parathyroid hormone (PTH) peptide analog in pre-clinical development for hypoparathyroidism (HP). Like native PTH, LA-PTH contains a methionine at position 8 that is predicted to be critical for function. We assessed the im...

Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.
https://doi.org/10.1007/s11154-020-09614-0
Reviews in Endocrine & Metabolic Disorders; Silva BC, Bilezikian JP

Nov 17th, 2020 - Both hypoparathyroidism (HypoPT), as well as its pathological counterpart, primary hyperparathyroidism (PHPT), can lead to skeletal abnormalities. Chronic deficiency of PTH in patients with HypoPT is associated with a profound reduction in bone re...

Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667728
BMC Nephrology; Saki F, Salehifar A et. al.

Nov 17th, 2020 - FGF23 controls serum l,25(OH)2D3 levels and phosphate homeostasis. This study evaluates the effects of ferritin on intact PTH, FGF23, and l,25(OH)2D3 in patients with major thalassemia. It also evaluates FGF23 changes in patients with hypoparathyr...

Multiple endocrine deficiencies are common in Hypoparathyroidism-Retardation-Dysmorphis...
https://doi.org/10.1210/clinem/dgaa807
The Journal of Clinical Endocrinology and Metabolism; David O, Barash G et. al.

Nov 5th, 2020 - The rare syndrome of hypoparathyroidism, retardation, and dysmorphism (OMIM #241410) is caused by the mutated tubulin chaperone E (TBCE) gene. This gene encodes a critical protein in the microtubule assembly pathway. To evaluate the endocrine prof...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, ...
https://doi.org/10.1089/thy.2017.0309
Thyroid : Official Journal of the American Thyroid Association; Orloff LA, Wiseman SM et. al.

May 31st, 2018 - Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association...

Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian ...
https://doi.org/10.20945/2359-3997000000015
Archives of Endocrinology and Metabolism; Maeda SS, Moreira CA et. al.

Apr 25th, 2018 - Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e M...

European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyr...
https://doi.org/10.1530/EJE-15-0628
European Journal of Endocrinology; Bollerslev J, Rejnmark L et. al.

Jul 14th, 2015 - Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vit...

Clinical practice guideline: improving voice outcomes after thyroid surgery.
https://doi.org/10.1177/0194599813487301
Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery; Chandrasekhar SS, Randolph GW et. al.

Jun 13th, 2013 - Thyroidectomy may be performed for clinical indications that include malignancy, benign nodules or cysts, suspicious findings on fine needle aspiration biopsy, dysphagia from cervical esophageal compression, or dyspnea from airway compression. Abo...

see more →

Drugs  115 results see all →

Clinicaltrials.gov  1,791 results

Autofluorescence and Indocyanine Green in Thyroid Surgery: A Systematic Review and Meta...
https://doi.org/10.1002/lary.29297
The Laryngoscope BIBLIOGRAPHY; Barbieri D, Indelicato P et. al.

Nov 28th, 2020 - To estimate the impact of optical techniques on prevention of post-operative hypocalcemia and hypoparathyroidism after total thyroidectomy. Systematic review and meta-analysis. A literature search was conducted in Pubmed, EMBASE, SCOPUS, and Cochr...

Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide Analogs.
https://doi.org/10.1210/endocr/bqaa216
Endocrinology Daley EJ, Khatri A et. al.

Nov 26th, 2020 - LA-PTH is a long-acting parathyroid hormone (PTH) peptide analog in pre-clinical development for hypoparathyroidism (HP). Like native PTH, LA-PTH contains a methionine at position 8 that is predicted to be critical for function. We assessed the im...

Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.
https://doi.org/10.1007/s11154-020-09614-0
Reviews in Endocrine & Metabolic Disorders; Silva BC, Bilezikian JP

Nov 17th, 2020 - Both hypoparathyroidism (HypoPT), as well as its pathological counterpart, primary hyperparathyroidism (PHPT), can lead to skeletal abnormalities. Chronic deficiency of PTH in patients with HypoPT is associated with a profound reduction in bone re...

Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667728
BMC Nephrology; Saki F, Salehifar A et. al.

Nov 17th, 2020 - FGF23 controls serum l,25(OH)2D3 levels and phosphate homeostasis. This study evaluates the effects of ferritin on intact PTH, FGF23, and l,25(OH)2D3 in patients with major thalassemia. It also evaluates FGF23 changes in patients with hypoparathyr...

Ergocalciferol - ergocalciferol capsule-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b43d7134-6c68-556b-e053-2995a90a38ef

Nov 15th, 2020 - Ergocalciferol Capsules are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

see more →

News  113 results

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.staging.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Drug Recall in US Causes Hypoparathyroid Patients Extreme Hardship
https://www.medscape.com/viewarticle/921971

Dec 1st, 2019 - The recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States over safety concerns about the product is gravely affecting the lives of American patients with severe hypoparathyroidism who need replacement PT...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.staging.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

see more →

Patient Education  5 results see all →